Quick Takeaways
- Richard Ian Griffiths filed SCHEDULE 13D/A for Silence Therapeutics Plc Ordinary Shares, nominal value of GBP0.05 per share (SLN).
- Disclosed ownership: 24%.
- Date of event: 25 Jun 2025.
Richard Ian Griffiths - 25 Jun 2025 SCHEDULE 13D/A Report for Silence Therapeutics Plc Ordinary Shares, nominal value of GBP0.05 per share (SLN)
- Filing Manager
- Richard Ian Griffiths
- Reporting Manager
- Richard Ian Griffiths
- Symbol
- SLN
- Shares outstanding
- 141,570,910 shares
- Disclosed Ownership
- 34,543,302 shares
- Ownership
- 24%
- Form type
- SCHEDULE 13D/A
- Filing time
- 25 Jun 2025, 10:24:36 UTC
- Date of event
- 25 Jun 2025
- Previous filing
- 08 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Richard Ian Griffiths disclosed 24% ownership in Silence Therapeutics Plc Ordinary Shares, nominal value of GBP0.05 per share (SLN) on 25 Jun 2025."
What Changed
- Previous schedule filing date: 08 May 2025.
- Current filing was accepted on 25 Jun 2025, 10:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Richard Ian Griffiths | 24% | 34,543,302 | 34,543,302 | 0 | /s/ Richard Ian Griffiths | Richard Ian Griffiths | 0001846370 |
| Ora Capital Limited | 14% | 19,221,525 | 19,221,525 | 0 | /s/ Richard Ian Griffiths | Director |